This expert volume in the Diagnostic Pathology series is an excellent point-of-care resource for practitioners at all levels of experience and training. Covering all areas of neoplastic and nonneoplastic diseases of the liver, biliary tree, pancreas, and gallbladder, it incorporates the most recent clinical, pathologic, and molecular knowledge in the field to provide a comprehensive overview of all key issues relevant to today's practice. Richly illustrated and easy to use, the fourth edition of Diagnostic Pathology: Hepatobiliary and Pancreas is an essential text for accurate, complete pathology reports, ideal as a day-to-day reference or as a reliable, one-stop training resource.
Presents clear delineations in challenging diagnoses for both nonneoplastic and neoplastic settings, illustrates novel tumor variants, uses updated terminology and society guidelines, and summarizes the role of molecular findings for diagnosis
Analyzes hundreds of diagnoses, each of which include critical diagnostic information such as definitions, epidemiology, clinical presentation, macro- and microscopic features, differential diagnoses, and pathologic interpretation pearls
Details the increasing use of molecular methods to diagnose cholestatic biliary liver conditions and other liver diseases of unknown etiology
Notes critical recent terminology changes, such as the switch from non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated steatotic liver disease (MASLD)
Explains novel variants of hepatocellular tumors and cholangiocarcinoma, and illustrates the integration of genomic findings in establishing the diagnosis and subclassification of tumors
Features more than 1,400 high-quality print images (with an additional 250+ images in the complimentary eBook), including histology and gross pathology images, full-color medical illustrations, clinical photographs, and radiology images
Reflects the most recent information from the 6th edition WHO Classification of Tumours, Digestive System Tumours, the American Association for the Study of Liver Disease (AASLD), and the European Association for the Study of the Liver (EASL), including new AASLD guidelines for hepatocellular carcinoma (HCC) and EASL guidelines for cholangiocarcinoma
Features a templated, highly formatted design; concise, bulleted text; key facts in each chapter; and an extensive index for easy reference
Includes a complimentary eBook with access to everything in the print version as well as additional text, figures, and references, with the ability to search, customize your content, make notes and highlights, and have content read aloud; additional digital ancillary content may publish up to 6 weeks following the publication date
